SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating beta-catenin Signaling. Jiang A, Wu W, Xu C, Mao L, et al. Invest Ophthalmol Vis Sci 2022;63:20.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang A, Wu W, Xu C, Mao L, et al. SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating beta-catenin Signaling. Invest Ophthalmol Vis Sci 2022;63:20.
PMID: 35297943